Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Bioventus (BVS) Receivables - Other (2020 - 2025)

Bioventus (BVS) has disclosed Receivables - Other for 6 consecutive years, with $177000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Other rose 132.89% year-over-year to $177000.0, compared with a TTM value of $177000.0 through Dec 2025, up 132.89%, and an annual FY2025 reading of $177000.0, up 132.89% over the prior year.
  • Receivables - Other was $177000.0 for Q4 2025 at Bioventus, up from $76000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $50.0 million in Q4 2021 and bottomed at $76000.0 in Q4 2024.
  • Average Receivables - Other over 5 years is $8.2 million, with a median of $257000.0 recorded in 2023.
  • The sharpest move saw Receivables - Other skyrocketed 225.61% in 2022, then plummeted 70.43% in 2024.
  • Year by year, Receivables - Other stood at $82000.0 in 2021, then surged by 225.61% to $267000.0 in 2022, then fell by 3.75% to $257000.0 in 2023, then crashed by 70.43% to $76000.0 in 2024, then surged by 132.89% to $177000.0 in 2025.
  • Business Quant data shows Receivables - Other for BVS at $177000.0 in Q4 2025, $76000.0 in Q4 2024, and $6.5 million in Q3 2024.